ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,616.84
      -0.32%
      US Tech 100
      18,991.20
      -1.09%
      Dow Jones
      41,240.52
      0.16%
      Brent Oil
      79.955
      -0.39%
      Bitcoin
      63,068.32
      0.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tourmaline Bio Inc (TRML)

      7. Tourmaline Bio Inc (TRML) News

      TRML

      Tourmaline Bio (TRML)

      Tourmaline Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TRML
      DateTimeSourceHeadlineSymbolCompany
      2:03PMiHub NewswireFeaturedELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET
      08/22/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      08/20/20246:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      08/08/20248:46AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRMLTourmaline Bio Inc
      08/08/20247:44AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      08/08/20247:30AMGlobeNewswire Inc.Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
      08/02/20244:30PMGlobeNewswire Inc.Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024NASDAQ:TRMLTourmaline Bio Inc
      06/27/20248:05AMGlobeNewswire Inc.Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial OfficerNASDAQ:TRMLTourmaline Bio Inc
      06/07/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      06/07/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      06/07/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRMLTourmaline Bio Inc
      05/23/20247:10AMGlobeNewswire Inc.Tourmaline Bio to Present at the Jefferies Global Healthcare ConferenceNASDAQ:TRMLTourmaline Bio Inc
      05/16/20247:00AMGlobeNewswire Inc.Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY TrialNASDAQ:TRMLTourmaline Bio Inc
      05/13/20244:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRMLTourmaline Bio Inc
      05/13/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      05/13/20247:00AMGlobeNewswire Inc.Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
      04/02/20247:00AMGlobeNewswire Inc.Avalo Therapeutics Appoints Biotech Leaders to Board of DirectorsNASDAQ:TRMLTourmaline Bio Inc
      03/19/20247:00AMGlobeNewswire Inc.Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:TRMLTourmaline Bio Inc
      02/27/20247:30AMGlobeNewswire Inc.Tourmaline Bio to Present at Upcoming Investor ConferencesNASDAQ:TRMLTourmaline Bio Inc
      02/14/20249:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRMLTourmaline Bio Inc
      02/14/20248:51PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
      02/09/20244:22PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TRMLTourmaline Bio Inc
      02/01/20248:00AMGlobeNewswire Inc.Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceNASDAQ:TRMLTourmaline Bio Inc
      01/29/20244:01PMGlobeNewswire Inc.Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:TRMLTourmaline Bio Inc
      01/26/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      01/26/20244:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
      01/25/20247:00AMGlobeNewswire Inc.Tourmaline Bio Announces Pricing of Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
      01/24/20249:20PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRMLTourmaline Bio Inc
      01/24/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRMLTourmaline Bio Inc
      01/24/20244:05PMGlobeNewswire Inc.Tourmaline Bio Announces Proposed Public Offering of Common StockNASDAQ:TRMLTourmaline Bio Inc
       Showing the most relevant articles for your search:NASDAQ:TRML

      Your Recent History

      USOTC
      EDNMY
      Edenred (CE)
      BIT
      IOT
      Seco
      Delayed Upgrade Clock